期刊文献+

盐酸莫西沙星耳用凝胶的制备及质量控制 被引量:1

Preparation and quality control of Moxifloxacin Hydrochloride Ear Gel
下载PDF
导出
摘要 目的制备盐酸莫西沙星耳用凝胶并建立其质量控制方法。方法以卡波姆-940为基质制备凝胶,采用高效液相色谱法测定盐酸莫西沙星含量,并考察其稳定性。结果盐酸莫西沙星进样量在0.4μg^3μg范围内与峰面积积分值线性关系良好(r=0.9999),平均回收率为99.82%(RSD=0.43%,n=9)。该制剂对家兔耳未见刺激性发生。结论本制剂制备工艺简单,质量控制易行,稳定性好,有良好的临床使用价值。 OBJECTIVE To prepare Moxifloxaein Hydrochloride Ear Gel and to establish a quality control method for the gel. METHODS The gel was prepared with carbopol 940 as base, the content of moxifolxacin hydroehioride was determined by HPLC and the stability of which was investigated. RESULTS The linear range of moxifloxacin hydroehioride was 0. 41~g ~ 3 p^g( r = 0. 9999 ), the average recovery was 99.82% ( RSD = 0. 43%, n = 9). The result of irritation test showed that the ear gel had no irritation. CONCLUSION The present formula is ra- tional,and the preparation technology is simple and the method for quality control is feasible andstable.
出处 《海峡药学》 2013年第12期31-32,共2页 Strait Pharmaceutical Journal
关键词 盐酸莫西沙星 耳用凝胶 制备 质量控制 Moxifloxaein Hydrochlofide Ear Gel Preparation Quality control
  • 相关文献

参考文献7

二级参考文献33

  • 1[1]Woodcock J M, Andrews J M, Boswell F J. et al. In vitro activity of BAY 12-8039, a new fluoroquinolone [J]. Antimicrob AgentsChemother , 1997;41:1101
  • 2[2]Hoogkamp-Korstanje J A, Roelofs-Winemse J. Comparative invitro activity of moxitloxacin against Gram-positive clinical isolates[J]. J Antimicrob Chemother, 2000; 45 (1): 31
  • 3[3]Sunderland J, Tobin C M, Hedges A J, et al. Antimicrobial activity of fluoroquinolone photodegradation products determinated byparallel-line bioassay and high performance liquid chromatography[J]. JAntimicrob Chemother, 2001; 47 (3): 271
  • 4[4]Stass H, Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administation in man [J]. JAntimicrob Chemother, 1999; 43 (Supple B): 83
  • 5[5]Stass H, Dalhoff A. Determination of BAY12-8039, a new 8methoxyquinolone, in human body fluids by high-performance liqnid chromatography with fluorescence detection using on-columnfocusing [J]. J Chromatogr Biomed Appl, 1997; 702 ( 1 ~ 2):163
  • 6[6]Moller J G, Stass H, Heinig R, et al. Capillary electrophoresiswith laser-induced fluorescence: a routine method to determinemoxifloxacin in human body fluids in very small sample volumes[J]. J Chromatog, 1998; 716:325
  • 7[1]Bull P,Make B.Acute exacerbations of chronic bronchitis-an international comparison.Chest,1998,113(3):1998~2048
  • 8[2]Sullivan JT,Woodruff M,Lettien J,et al.Pharmacokinetics(PK)and tolerability of the new mothoxyquinolone BAY 12-8039:10 days' treatment at 400mg.8th ECCMID,1997.359
  • 9[3]Heimer-Bau M,Beyer G,Stass H,et al.Pharmacokinetics(PK)and influence of moxifloxacin(MOX)on bacterial intestinal flora in young male subjects.38th ICCAAC,1998.16
  • 10[4]Stass HH,Kubitza D.Study to evaluate the interaction between moxifloxacin(M)and iron supplements(FE)[abstract T154].Anti-infect Drug Chemother,1998,16(1):74

共引文献68

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部